Search Constraints
Search Results
Select an image to start the slideshow
Noradrenergic dysfunction in neurodegenerative disease
1 of 25
The Effects of Chronic, Oral Deltamethrin Exposure on Nigrostriatal Dopamine Receptors: A Model for Pyrethroid Toxicity in Adults
2 of 25
Social Determinants of Parkinson’s Disease: Associations Between Education, Mental Health, and Exercise Among Patients with PD
3 of 25
LRRK2 and Environmental Effects on Dopamine Systems within the Gut-Brain Axis: A Parkinson’s Disease Pathology Focus
4 of 25
The impact of LRRK2 expression and kinase activity in gene by environment mouse models of Parkinson’s disease
5 of 25
Cannabinoid type 2 receptors regulate striatal inflammation following alpha synuclein-induced nigral degeneration in rat model of Parkinson’s disease
6 of 25
Innate and Adaptive Immune System Crosstalk in Parkinson's Disease
7 of 25
Gene-Environment Interplay in Parkinson’s Disease Pathogenesis: The Role of Gastrointestinal Inflammation and Regulator of G-protein Signaling 10 in the Gut-Brain Axis
8 of 25
Abnormal muscle activity during balance before and after an exercise-based balance rehabilitation in people with Parkinson’s disease
9 of 25
Ultrastructural Plasticity of Pallidothalamic GABAergic Terminals in Parkinson’s Disease: A 3D Electron Microscopy Study in the Parvocellular Ventral Anterior and Centromedian Thalamic Nuclei in MPTP-Treated Parkinsonian Monkeys
10 of 25
A role for the synaptic vesicle glycoprotein 2C (SV2C) in
dopamine homeostasis and Parkinson's disease
11 of 25
Disruption of Monoamine Homeostasis in Models of Neurological and
Neuroendocrine Diseases
12 of 25
Synaptic Vesicle Glycoprotein 2C (SV2C) in Parkinson's Disease-Related Striatal Vesicular Dysfunction
13 of 25
A Cross-Sectional Study of Set Shifting Impairments and Falling in Individuals with and without Parkinson's Disease
14 of 25
Environmental & Pharmaceutical Exposures alter the function of VMAT2 and Promote Neurodegeneration in Parkinson's Disease
15 of 25
Effects of Dopamine D1-Like Receptor Activation in the Internal Pallidal Segment and the Substantia Nigra Pars Reticulata of Normal and Parkinsonian Primates
16 of 25
Reduced vesicular storage of catecholamines in the pathogenesis of
Parkinson's Disease
17 of 25
Gastrointestinal Symptoms in Parkinson's Disease: Prevalence,
Characterization, and Relationship to Disease Stage
18 of 25
Glutamatergic Inputs to the Monkey Subthalamic Nucleus: A
Comparison of Relative Abundance, Synaptology and Functional
Connectivity in Normal versus Parkinsonian Conditions.
19 of 25
Impaired vesicular storage of norepinephrine and serotonin in Parkinson's disease-related pathogenesis
20 of 25
Pesticides and Parkinson's disease: Attributable Risk of
Occupational Exposure and Neurochemical Analysis of Sub-Chronic
Environmental Exposure
21 of 25
RING FINGER PROTEIN 11 (RNF11) MEDIATES NF-κB SIGNALING AND
DOPAMINERGIC NEURODEGENERATION
22 of 25
Optimized Delivery of C3 Transferase by Lentiviral Vectors forCNS Injury Therapy
23 of 25
Loss of the Cortical Monoamine Projection Systems in the
MPTP-treated Nonhuman Primate Model of Parkinson's Disease
24 of 25
EFFECTS OF VITAMIN D SUPPLEMENTATION ON MOTOR SYMPTOMS OF
PATIENTS WITH PARKINSON'S DISEASE
25 of 25